| Trial ID: | L1856 |
| Source ID: | NCT04375020
|
| Associated Drug: |
Gaba
|
| Title: |
GABA and Beta-cell Regeneration
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: GABA
|
| Outcome Measures: |
Primary: gaba decrease anti gad antibodies, gaba 750 mg daily for type 1 diabetes patients, 6 months|gaba improve c peptide levels, gaba 750 mg pe day for type 1 diabetes patients, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Ministry of Health and Population, Egypt
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2019-11-01
|
| Completion Date: |
2020-05-02
|
| Results First Posted: |
|
| Last Update Posted: |
2020-05-07
|
| Locations: |
Mahmoud Younis, Cairo, 11865, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT04375020
|
